In The News,
Lindsay Bealor Greenleaf speaks with Fierce Healthcare about the impact of the newly-enacted pharmacy gag clause laws
[el-text]
Written by Paige Minemyer
***excerpt***
Lindsay Bealor Greenleaf, director at ADVI, told Fierce Healthcare that, though there is limited data around the gag clauses, the impact could be significant. Recent studies suggest that 23% of commercially insured patients overpay for medications, a significant piece. As the biggest pharmacy benefit managers (PBMs) hold a major monopoly over the market, it was hard for pharmacies to push back on contractual gag clauses that may hurt patients, Greenleaf said. “I think that market power piece is notable,” Greenleaf said. “Pharmacists can’t just cherry-pick the pieces [of contracts] they don’t like.”
***end excerpt***
***
[/el-text]